rs200669099
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_012144.4(DNAI1):c.1644G>A(p.Trp548*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,614,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_012144.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAI1 | NM_012144.4 | c.1644G>A | p.Trp548* | stop_gained | Exon 17 of 20 | ENST00000242317.9 | NP_036276.1 | |
DNAI1 | NM_001281428.2 | c.1656G>A | p.Trp552* | stop_gained | Exon 17 of 20 | NP_001268357.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251378Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135864
GnomAD4 exome AF: 0.000112 AC: 164AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.000103 AC XY: 75AN XY: 727248
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74336
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:4
This sequence change creates a premature translational stop signal (p.Trp548*) in the DNAI1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAI1 are known to be pathogenic (PMID: 16858015, 29363216). This variant is present in population databases (rs200669099, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with primary ciliary dyskinesia (PMID: 16858015, 21270641). ClinVar contains an entry for this variant (Variation ID: 240854). For these reasons, this variant has been classified as Pathogenic. -
- -
The p.W548* pathogenic mutation (also known as c.1644G>A), located in coding exon 17 of the DNAI1 gene, results from a G to A substitution at nucleotide position 1644. This changes the amino acid from a tryptophan to a stop codon within coding exon 17. This mutation was confirmed in trans with a second DNAI1 mutation in an individual with primary ciliary dykinesia and outer dynein arm defects on electron microscopy (Zariwala MA et al. Am. J. Respir. Crit. Care Med., 2006 Oct;174:858-66). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
- -
Kartagener syndrome Pathogenic:2
- -
The DNAI1 c.1644G>A (p.Trp548Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. The p.Trp548Ter variant has been reported in a compound heterozygous state in two patients with neonatal respiratory distress and sinusitis as well as outer dynein arm defect on electron microscopy (Zariwala et al. 2006; Berg et al. 2011). Family studies for one patient found the p.Trp548Ter variant was inherited from the healthy father. The variant was absent from 113 control subjects and is reported at a frequency of 0.000071 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the evidence in the literature and the potential impact of stop-gained variants, the p.Trp548Ter variant is classified as likely pathogenic for primary ciliary dyskinesia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at